Angiotech Pharmaceuticals Inc. (ANPI, ANP.TO) said that its corporate partner, Boston Scientific (BSX), has reported two-year data from its SYNTAX clinical trial comparing percutaneous coronary intervention using the Taxus Express Paclitaxel-Eluting Coronary Stent System to coronary artery bypass graft surgery.
The overall results demonstrated no statistically significant difference between PCI and CABG in the composite safety endpoint.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.